Life Institute Provides Technical Support to COVID-19 Diagnostic Kit Companies View original image


[Asia Economy Reporter Junho Hwang] The Korea Research Institute of Bioscience and Biotechnology (KRIBB) visited the COVID-19 diagnostic kit companies 'SugenTech' and 'Bioneer' on the 20th to discuss technological cooperation.


The event was held as part of the 'KRIBB Tech-Bridge' program, newly launched this year to discover demand-driven technologies and strengthen technological cooperation through collaboration with bio companies.


KRIBB formed a technology cooperation team consisting of about 20 experts in the fields of in vitro diagnostics and DNA synthesis, led by Director Jang-Sung Kim, and visited SugenTech and Bioneer, KRIBB family companies (bio companies founded using KRIBB's technology).


Bioneer is the first bio venture company in Korea, founded by CEO Han-O Park while he was working at KRIBB. SugenTech was also founded by CEO Mi-Jin Son after her tenure at KRIBB.


Based on the results of this field visit, KRIBB plans to strengthen market-oriented research and development (R&D) by applying industry demand technologies to research sites. KRIBB will hold the Tech-Bridge program four times annually and plans to visit KRIBB family companies, bio sector companies, and pharmaceutical companies.



Director Jang-Sung Kim stated, "Taking this visit as an opportunity, we will shift from laboratory-centered R&D to technology development that meets the needs of the industrial field, thereby strengthening the role of central research institutes for small and medium-sized enterprises and mid-sized companies."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing